{"recordsFiltered":50813,"recordsTotal":50813,"next":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&ordering=completion_date&start=40800","previous":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&ordering=completion_date&start=40200","results":[{"registry_id":"NCT06699797","publication_url":"https://clinicaltrials.gov/study/NCT06699797","title":"Pivotal Clinical Trial Evaluating the Safety and Efficacy of the Fully Implanted Acclaim Cochlear Implant","has_exemption":false,"start_date":"2025-02-06","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Envoy Medical Corporation","sponsor_slug":"envoy-medical-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06289491","publication_url":"https://clinicaltrials.gov/study/NCT06289491","title":"Randomized Trial of Hydrus Microstent Versus Goniotomy","has_exemption":false,"start_date":"2025-02-14","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts Eye and Ear Infirmary","sponsor_slug":"massachusetts-eye-and-ear-infirmary","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06736704","publication_url":"https://clinicaltrials.gov/study/NCT06736704","title":"A Phase 1/2, Open-Label Dose Escalation and Expansion Study of SNV4818 as Monotherapy or in Combination With Other Anticancer Agents in Participants With Advanced Solid Tumors","has_exemption":false,"start_date":"2025-02-20","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Pikavation Therapeutics, Inc.","sponsor_slug":"pikavation-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06281925","publication_url":"https://clinicaltrials.gov/study/NCT06281925","title":"A Phase II Randomized Interventional Pilot Study for Colon Cancer Patients Receiving Oxaliplatin: Benefits of Cryotherapy in Prevention of Peripheral Neuropathy","has_exemption":false,"start_date":"2025-03-13","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06922084","publication_url":"https://clinicaltrials.gov/study/NCT06922084","title":"A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects","has_exemption":false,"start_date":"2025-03-17","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Berkeley Eye Center","sponsor_slug":"berkeley-eye-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06799065","publication_url":"https://clinicaltrials.gov/study/NCT06799065","title":"A Phase 1/2, Open-Label, Dose-Escalation and Expansion First-In-Human Study of ATX-295, an Oral Inhibitor of the Kinesin Motor Protein KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Locally Advanced or Metastatic Solid Tumors, Including High-Grade Serous Ovarian Cancer","has_exemption":false,"start_date":"2025-03-21","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Accent Therapeutics","sponsor_slug":"accent-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06453785","publication_url":"https://clinicaltrials.gov/study/NCT06453785","title":"Comparing pOrtable MRI and TRUS-Fusion Prostate Biopsy to Assess aCcuracy of Prostate Cancer Detection","has_exemption":false,"start_date":"2025-03-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Imperial College London","sponsor_slug":"imperial-college-london","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06862557","publication_url":"https://clinicaltrials.gov/study/NCT06862557","title":"Effects of PEMF Treatment on Patients With Mild to Moderate Dementia in a Controlled Pilot Study","has_exemption":false,"start_date":"2025-04-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Herrick Medical LLC","sponsor_slug":"herrick-medical-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06925724","publication_url":"https://clinicaltrials.gov/study/NCT06925724","title":"A Phase 2 Study of Ivonescimab (Bispecific Antibody Against PD1 and VEGF) For the Treatment of Endometrial (EC) and Cervical (CC) Cancers","has_exemption":false,"start_date":"2025-04-04","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06621251","publication_url":"https://clinicaltrials.gov/study/NCT06621251","title":"Phase 2 Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Chronic Prosthetic Joint Infection of the Knee or Hip Without Exchange Arthroplasty","has_exemption":false,"start_date":"2025-04-08","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Trellis Bioscience LLC","sponsor_slug":"trellis-bioscience-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07715656","publication_url":"https://clinicaltrials.gov/study/NCT07715656","title":"Assessing Outcomes of Coil Embolization for Unilateral vs Bilateral Chronic Subdural Hematomas: A Randomized Controlled Trial.","has_exemption":false,"start_date":"2025-04-09","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Lahey Clinic","sponsor_slug":"lahey-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06866691","publication_url":"https://clinicaltrials.gov/study/NCT06866691","title":"Seizure Prevention in Traumatic Brain Injury: A Comparative Effectiveness Study of Levetiracetam and Lacosamide","has_exemption":false,"start_date":"2025-04-18","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06957327","publication_url":"https://clinicaltrials.gov/study/NCT06957327","title":"A Phase 1b/2 Study of ERAS-601 SHP2 Inhibitor as a Monotherapy in Patients With Advanced and Progressing Chordoma","has_exemption":false,"start_date":"2025-04-25","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06470035","publication_url":"https://clinicaltrials.gov/study/NCT06470035","title":"A Randomized, Double Blind Sham Controlled Clinical Trial to Evaluate the Efficacy of Electrical Vestibular Nerve Stimulation (VeNS), Compared to a Sham Control for Treatment of Major Depressive Disorder (MDD) - Modius Mood Study","has_exemption":false,"start_date":"2025-04-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Neurovalens Ltd.","sponsor_slug":"neurovalens-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06742801","publication_url":"https://clinicaltrials.gov/study/NCT06742801","title":"PELE IDE Clinical Study, Peripheral Onyx™ Liquid Embolic Safety and Effectiveness of The Onyx™ LES for Embolization of Arterial Hemorrhage in the Peripheral Vasculature","has_exemption":false,"start_date":"2025-05-09","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Medtronic Endovascular","sponsor_slug":"medtronic-endovascular","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07020026","publication_url":"https://clinicaltrials.gov/study/NCT07020026","title":"Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease Using [18F]PI-2620: A High-resolution PET Imaging Study Using NeuroEXPLORER (NX PI-2160 in PD)","has_exemption":false,"start_date":"2025-05-12","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Michael J. Fox Foundation for Parkinson's Research","sponsor_slug":"michael-j-fox-foundation-for-parkinsons-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06834165","publication_url":"https://clinicaltrials.gov/study/NCT06834165","title":"A Phase IV Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy","has_exemption":false,"start_date":"2025-05-20","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"ARS Pharmaceuticals, Inc.","sponsor_slug":"ars-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06999278","publication_url":"https://clinicaltrials.gov/study/NCT06999278","title":"LIGHT - Levothyroxine for Isolated Gestational HypoThyroidism in Women With Recurrent Pregnancy Loss: a Multicenter Randomized, Double-blind, Placebo-controlled Trial - a Study Protocol","has_exemption":false,"start_date":"2025-06-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Women's Hospital School Of Medicine Zhejiang University","sponsor_slug":"womens-hospital-school-of-medicine-zhejiang-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06735534","publication_url":"https://clinicaltrials.gov/study/NCT06735534","title":"The ReMATCH Study is a Prospective, Single Arm, Open Label, Multi-center, Study Utilizing the FARAPULSE PFA System, Including the FARAWAVE and FARAPOINT PFA Catheters","has_exemption":false,"start_date":"2025-06-03","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06895473","publication_url":"https://clinicaltrials.gov/study/NCT06895473","title":"A Phase 2 Study of Prophylactic IT Chemotherapy to Prevent High-Grade Chimeric Antigen Receptor (CAR) T-Cell-Associated Neurotoxicity Syndrome","has_exemption":false,"start_date":"2025-06-04","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"OHSU Knight Cancer Institute","sponsor_slug":"ohsu-knight-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07617506","publication_url":"https://clinicaltrials.gov/study/NCT07617506","title":"Neural Basis of Human Working Memory","has_exemption":false,"start_date":"2025-06-04","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06968494","publication_url":"https://clinicaltrials.gov/study/NCT06968494","title":"Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction Following Radical Prostatectomy","has_exemption":false,"start_date":"2025-06-05","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Comphya Inc.","sponsor_slug":"comphya-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06999304","publication_url":"https://clinicaltrials.gov/study/NCT06999304","title":"Personalized Accelerated Theta Burst Transcardial Magnetic Stimulation in Mild Traumatic Brain Injury","has_exemption":false,"start_date":"2025-06-18","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"HealthPartners Institute","sponsor_slug":"healthpartners-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07033026","publication_url":"https://clinicaltrials.gov/study/NCT07033026","title":"A Phase 2, Multicenter, Randomized, Double Blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of NGM120 in Participants With Colorectal Cancer Who Have Cancer Cachexia","has_exemption":false,"start_date":"2025-06-25","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"NGM Biopharmaceuticals, Inc","sponsor_slug":"ngm-biopharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06740890","publication_url":"https://clinicaltrials.gov/study/NCT06740890","title":"A Proof of Concept Study of Time Limited Exercise Plus Olanzapine-samidorphan for the Prevention of Early Weight Gain","has_exemption":false,"start_date":"2025-06-26","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"New York State Psychiatric Institute","sponsor_slug":"new-york-state-psychiatric-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07113522","publication_url":"https://clinicaltrials.gov/study/NCT07113522","title":"A Phase 2, Multi-Center, Platform Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics With Multiple Therapies in Participants With Active Crohn's Disease or Active Ulcerative Colitis (ASCEND-IBD)","has_exemption":false,"start_date":"2025-06-26","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Mirador Therapeutics, Inc.","sponsor_slug":"mirador-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06665100","publication_url":"https://clinicaltrials.gov/study/NCT06665100","title":"Efficacy and Safety of PUL-042 Inhalation Solution in Reducing Lower Respiratory Tract Complications in Patients With Hematologic Malignancies and Recipients of Hematopoietic Stem Cell Transplantation (HSCT) With Documented Viral Infections With PIV, hMPV or RSV","has_exemption":false,"start_date":"2025-06-27","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Pulmotect, Inc.","sponsor_slug":"pulmotect-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06998524","publication_url":"https://clinicaltrials.gov/study/NCT06998524","title":"A Phase III, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Emicizumab Prophylaxis in Patients With Type 3 Von Willebrand Disease","has_exemption":false,"start_date":"2025-06-27","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07019259","publication_url":"https://clinicaltrials.gov/study/NCT07019259","title":"Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors","has_exemption":false,"start_date":"2025-06-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07025720","publication_url":"https://clinicaltrials.gov/study/NCT07025720","title":"Accelerated Intermittent Theta Burst Stimulation for Adolescent and Young Adult Depression With Elevated Suicide Risk","has_exemption":false,"start_date":"2025-07-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07095660","publication_url":"https://clinicaltrials.gov/study/NCT07095660","title":"RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-IRL)","has_exemption":false,"start_date":"2025-07-02","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Intervene, Inc.","sponsor_slug":"intervene-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07064486","publication_url":"https://clinicaltrials.gov/study/NCT07064486","title":"A Phase 3, Randomized, Open Label Trial Comparing Efficacy and Safety of BGM0504 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Patients With Type 2 Diabetes","has_exemption":false,"start_date":"2025-07-04","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"BrightGene Bio-Medical Technology Co., Ltd.","sponsor_slug":"brightgene-bio-medical-technology-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217392","publication_url":"https://clinicaltrials.gov/study/NCT07217392","title":"Left Bundle Branch Area Pacing (LBBAP) PMCF Study","has_exemption":false,"start_date":"2025-07-24","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Abbott Medical Devices","sponsor_slug":"abbott-medical-devices","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06990399","publication_url":"https://clinicaltrials.gov/study/NCT06990399","title":"A Randomized, Double-masked, Sham-controlled, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal Tabirafusp Alfa (KSI-101) in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK","has_exemption":false,"start_date":"2025-07-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Kodiak Sciences Inc","sponsor_slug":"kodiak-sciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07079761","publication_url":"https://clinicaltrials.gov/study/NCT07079761","title":"Facilitation of Extinction Retention and Reconsolidation Blockade by IV Allopregnanolone in PTSD.","has_exemption":false,"start_date":"2025-08-04","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06864403","publication_url":"https://clinicaltrials.gov/study/NCT06864403","title":"Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch","has_exemption":false,"start_date":"2025-08-12","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07287176","publication_url":"https://clinicaltrials.gov/study/NCT07287176","title":"Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System in Symptomatic Benign Thyroid Nodules (PRECISE-BTN)","has_exemption":false,"start_date":"2025-08-21","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Pulse Biosciences, Inc.","sponsor_slug":"pulse-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04750564","publication_url":"https://clinicaltrials.gov/study/NCT04750564","title":"BreEStim for Post-Stroke Motor Recovery","has_exemption":false,"start_date":"2025-09-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04752319","publication_url":"https://clinicaltrials.gov/study/NCT04752319","title":"BreEStim for Post-Stroke Motor Recovery","has_exemption":false,"start_date":"2025-09-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06968143","publication_url":"https://clinicaltrials.gov/study/NCT06968143","title":"Evaluating the Impact of Remote Therapeutic Monitoring on Knee Arthroplasty Recovery","has_exemption":false,"start_date":"2025-09-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06915662","publication_url":"https://clinicaltrials.gov/study/NCT06915662","title":"Pain Outcomes After Digital Amputation Using Tulavi Allay™ Nerve Cap: A Prospective Trial for Safety and Efficacy","has_exemption":false,"start_date":"2025-09-20","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07161999","publication_url":"https://clinicaltrials.gov/study/NCT07161999","title":"Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, 24-Week Study With Additional 24-Week Blinded Active Extension and Open Label Extension to Evaluate the Safety and Efficacy of COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)","has_exemption":false,"start_date":"2025-10-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Coya Therapeutics","sponsor_slug":"coya-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07205120","publication_url":"https://clinicaltrials.gov/study/NCT07205120","title":"Fluid Guided Heart Failure Treatment","has_exemption":false,"start_date":"2025-10-08","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Bodyport Inc.","sponsor_slug":"bodyport-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220811","publication_url":"https://clinicaltrials.gov/study/NCT07220811","title":"Phase 2b Randomized, Double-Blind, Placebo-Controlled Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy","has_exemption":false,"start_date":"2025-10-22","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"RAPT Therapeutics, Inc., a member of the GSK plc group of companies","sponsor_slug":"rapt-therapeutics-inc-a-member-of-the-gsk-plc-group-of-companies","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06959121","publication_url":"https://clinicaltrials.gov/study/NCT06959121","title":"Pulse Biosciences' CellFX nsPFA Cardiac Surgery Clamp System for the Treatment of Atrial Fibrillation During Concomitant Cardiac Surgery","has_exemption":false,"start_date":"2025-10-23","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Pulse Biosciences, Inc.","sponsor_slug":"pulse-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07889687","publication_url":"https://clinicaltrials.gov/study/NCT07889687","title":"Lidocaine Jelly +/- Lidocaine Periurethral Injection for Urethral Bulking Analgesia: A Single-Blind Randomized Controlled Trial","has_exemption":false,"start_date":"2025-10-26","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06804811","publication_url":"https://clinicaltrials.gov/study/NCT06804811","title":"A Phase 3, Randomized, Double-Blind, Efficacy, and Safety Study of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo","has_exemption":false,"start_date":"2025-11-13","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06658899","publication_url":"https://clinicaltrials.gov/study/NCT06658899","title":"A Phase 2, Double-Blind, Repeat-Dose, Placebo-Controlled Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CRD-4730 In Participants With Catecholaminergic Polymorphic Ventricular Tachycardia","has_exemption":false,"start_date":"2025-12-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Cardurion Pharmaceuticals, Inc.","sponsor_slug":"cardurion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07400952","publication_url":"https://clinicaltrials.gov/study/NCT07400952","title":"Multicenter, Randomized, Double-Masked, Placebo-Controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus","has_exemption":false,"start_date":"2025-12-23","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Glaukos Corporation","sponsor_slug":"glaukos-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221734","publication_url":"https://clinicaltrials.gov/study/NCT07221734","title":"Randomised, Multicentre, Multinational, Double-Blind Integrated Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 (Proposed Nivolumab Biosimilar) Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced (Unresectable or Metastatic) Melanoma (LEON Study)","has_exemption":false,"start_date":"2025-12-29","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"mAbxience Research S.L.","sponsor_slug":"mabxience-research-sl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07351071","publication_url":"https://clinicaltrials.gov/study/NCT07351071","title":"A Prospective, Multicenter, Single-arm, Post Market Study to Evaluate the Safety and Performance of the Signia™ Circular Stapler With Tri-Staple™ Technology in Elective Open or Minimally Invasive Left-sided Colon, Sigmoid, and Rectal Resections (SECURE)","has_exemption":false,"start_date":"2025-12-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Medtronic - MITG","sponsor_slug":"medtronic-mitg","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07222969","publication_url":"https://clinicaltrials.gov/study/NCT07222969","title":"An Open-label, Dose-escalation and Dose-expansion Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic (PK) Characteristics, and Preliminary Efficacy of VIB305 in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2026-01-12","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Vibrant Sciences Limited","sponsor_slug":"vibrant-sciences-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07553273","publication_url":"https://clinicaltrials.gov/study/NCT07553273","title":"The Effect of Vibratory Anesthesia on Patient Pain Perception in Corticosteroid Injections of the Upper Extremity","has_exemption":false,"start_date":"2026-01-14","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Medical Branch, Galveston","sponsor_slug":"the-university-of-texas-medical-branch-galveston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07282743","publication_url":"https://clinicaltrials.gov/study/NCT07282743","title":"A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Tolerability of GL0034 Among Type II Diabetes Mellitus Subjects Who Are Obese or Overweight With Weight-related Comorbidities","has_exemption":false,"start_date":"2026-01-20","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Sun Pharmaceutical Industries Limited","sponsor_slug":"sun-pharmaceutical-industries-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07141342","publication_url":"https://clinicaltrials.gov/study/NCT07141342","title":"The Fast In-Bed Tracking (FIT) System Lifestyle Intervention","has_exemption":false,"start_date":"2026-02-16","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Jonathan Pearlman","sponsor_slug":"jonathan-pearlman","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07486713","publication_url":"https://clinicaltrials.gov/study/NCT07486713","title":"A Multi-Center, Open-Label, Drug-Drug Interaction Study to Evaluate the Effect of Olutasidenib on the Pharmacokinetics of CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP3A4, and OATP1B1 Substrates in Patients With IDH1 Mutation-Positive Malignancies Being Treated With Olutasidenib","has_exemption":false,"start_date":"2026-02-23","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Rigel Pharmaceuticals","sponsor_slug":"rigel-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07369076","publication_url":"https://clinicaltrials.gov/study/NCT07369076","title":"A Phase 1b/2 Study to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.","has_exemption":false,"start_date":"2026-03-04","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Nura Bio","sponsor_slug":"nura-bio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07306182","publication_url":"https://clinicaltrials.gov/study/NCT07306182","title":"A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of SGC001 Injection in Chinese Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction and Planned for Primary Percutaneous Coronary Intervention (pPCI)","has_exemption":false,"start_date":"2026-03-09","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Beijing Sungen Biomedical Technology Co., Ltd","sponsor_slug":"beijing-sungen-biomedical-technology-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07523191","publication_url":"https://clinicaltrials.gov/study/NCT07523191","title":"Prospective Validation of a Reduced-Montage TMS-EEG Complexity Algorithm (Presence-IP1.0) to Differentiate Conscious and Unconscious States Across Wakefulness and Sleep","has_exemption":false,"start_date":"2026-03-18","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07078604","publication_url":"https://clinicaltrials.gov/study/NCT07078604","title":"A Phase II Trial of the Immunogenicity of a DNA Plasmid-Based Vaccine (STEMVAC) Encoding Th1 Selective Epitopes From Five Antigens Associated With Breast Cancer Stem Cells (MDM2, YB1, SOX2, CDH3, CD105) in Patients With Metastatic Triple-Negative Breast Cancer","has_exemption":false,"start_date":"2026-03-24","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07086534","publication_url":"https://clinicaltrials.gov/study/NCT07086534","title":"A Clinical Study of GeminiOne Transcatheter Edge-to-Edge Repair (TEER) System for the Treatment of Severe, Symptomatic Mitral Regurgitation (MR).","has_exemption":false,"start_date":"2026-03-26","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Sierra Valve LLC","sponsor_slug":"sierra-valve-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07637331","publication_url":"https://clinicaltrials.gov/study/NCT07637331","title":"The Effect of Respiratory Muscle Training on Cognitive Performance","has_exemption":false,"start_date":"2026-03-27","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07477171","publication_url":"https://clinicaltrials.gov/study/NCT07477171","title":"Comparison of Two Root Canal Filling Materials in Non-Surgical Endodontic Retreatment: A Randomized Controlled Clinical Trial","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Santiago de Compostela","sponsor_slug":"university-of-santiago-de-compostela","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07504198","publication_url":"https://clinicaltrials.gov/study/NCT07504198","title":"Neuroprotective Effect of Memantine and Rosuvastatin Against Oxaliplatin Induced Peripheral Neuropathy in Patients With Colorectal Cancer","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Tanta University","sponsor_slug":"tanta-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06333041","publication_url":"https://clinicaltrials.gov/study/NCT06333041","title":"Randomized, Double-Blind, Placebo-Controlled Cross-Over Study to Evaluate the Effects of Cannabidiol on Neurobehavioral and Function Outcomes in Sanfilippo Syndrome","has_exemption":false,"start_date":"2026-04-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","sponsor_slug":"lundquist-institute-for-biomedical-innovation-at-harbor-ucla-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07175441","publication_url":"https://clinicaltrials.gov/study/NCT07175441","title":"A Phase 2a, Multicenter, Randomized, Open-Label Study to Assess the Efficacy, Safety, and Tolerability of RBS2418 in Combination With Tremelimumab Plus Durvalumab for Participants With Advanced Unresectable Hepatocellular Carcinoma","has_exemption":false,"start_date":"2026-04-10","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Riboscience, LLC.","sponsor_slug":"riboscience-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07544251","publication_url":"https://clinicaltrials.gov/study/NCT07544251","title":"The Effects of Sarecycline Versus Doxycycline on the Gut Microbiome and Skin Microbiome in Acne.","has_exemption":false,"start_date":"2026-04-20","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Integrative Skin Science and Research","sponsor_slug":"integrative-skin-science-and-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05966896","publication_url":"https://clinicaltrials.gov/study/NCT05966896","title":"Epidural Stimulation to Restore Voluntary Movement Following Spinal Cord Injury: Spared Fibers Proof-of-concept Study","has_exemption":false,"start_date":"2026-04-22","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07223008","publication_url":"https://clinicaltrials.gov/study/NCT07223008","title":"A Pilot Study of Safety and Feasibility of Bilateral Middle Meningeal Artery Embolization (bMMAE) in Patients With Refractory Chronic Migraine Headache: The MMAE-MIGRAINE Trial","has_exemption":false,"start_date":"2026-04-24","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224958","publication_url":"https://clinicaltrials.gov/study/NCT07224958","title":"ROAM OA: Functional and Patient Reported Outcomes Wearing a Knee Brace for Unicompartmental OA","has_exemption":false,"start_date":"2026-04-27","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07680205","publication_url":"https://clinicaltrials.gov/study/NCT07680205","title":"An Experimental Pilot Study to Investigate Changes in Catecholamine Synthesis and Metabolism in Patients With Molecularly Profiled Phaeochromocytoma and Paraganglioma Taking Belzutifan","has_exemption":false,"start_date":"2026-04-27","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Cambridge University Hospitals NHS Foundation Trust","sponsor_slug":"cambridge-university-hospitals-nhs-foundation-trust","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06944795","publication_url":"https://clinicaltrials.gov/study/NCT06944795","title":"A Short Wave Infrared Otoscope for Objective Middle Ear Effusion Diagnosis","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07342595","publication_url":"https://clinicaltrials.gov/study/NCT07342595","title":"Clinical Performance of an Intraoral Scanner With Integrated Caries Detection","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Albert Mehl","sponsor_slug":"albert-mehl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07565701","publication_url":"https://clinicaltrials.gov/study/NCT07565701","title":"Safety and Efficacy of a Phased Transition From Epogen to Three Times Weekly Oral Vadadustat for the Treatment of Anemia in Subjects Receiving In-Center Hemodialysis","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Geoff Block","sponsor_slug":"geoff-block","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07592520","publication_url":"https://clinicaltrials.gov/study/NCT07592520","title":"Flush, Lyse, Operate: A Pilot Trial of Step-Wise Escalation for Pleural Infection: FLO Trial","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Dartmouth-Hitchcock Medical Center","sponsor_slug":"dartmouth-hitchcock-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07517770","publication_url":"https://clinicaltrials.gov/study/NCT07517770","title":"Effectiveness of Artificial-Intelligence (AI) Bolus Priming Added to an Existing Fully Automated Control Algorithm (AIDANET)","has_exemption":false,"start_date":"2026-05-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Sue Brown","sponsor_slug":"sue-brown","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07346066","publication_url":"https://clinicaltrials.gov/study/NCT07346066","title":"A Phase 3 Multi-Center Efficacy Study of Filricianine Injection in Patients Undergoing Robotic-Assisted Colorectal Surgery Using the da Vinci Surgical System With Firefly® Fluorescence Imaging","has_exemption":false,"start_date":"2026-05-14","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Intuitive Surgical","sponsor_slug":"intuitive-surgical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07633470","publication_url":"https://clinicaltrials.gov/study/NCT07633470","title":"RESOLVE: A Phase 4, Open-label Study to Assess the Effect of Zunveyl on Safety and Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Adults With Mild to Moderate Alzheimer's Disease","has_exemption":false,"start_date":"2026-05-20","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Alpha Cognition, Inc","sponsor_slug":"alpha-cognition-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06748144","publication_url":"https://clinicaltrials.gov/study/NCT06748144","title":"Intraosseous vs. Intravenous Vancomycin Administration in Spine Surgery","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07517679","publication_url":"https://clinicaltrials.gov/study/NCT07517679","title":"Effect of Post-Induction Methadone on Postoperative Pain, Opioid Use, and Recovery in Spine Surgery","has_exemption":false,"start_date":"2026-06-10","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Brandon Knopp","sponsor_slug":"brandon-knopp","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07641517","publication_url":"https://clinicaltrials.gov/study/NCT07641517","title":"Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY4065967 for the Treatment of Osteoarthritis","has_exemption":false,"start_date":"2026-06-25","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07487246","publication_url":"https://clinicaltrials.gov/study/NCT07487246","title":"Effects of Paracervical Block With Combined Ketorolac and Lidocaine on Perceived Pain in Osmotic Dilator Placement for Abortion, a Randomized Controlled Trial","has_exemption":false,"start_date":"2026-06-29","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07627529","publication_url":"https://clinicaltrials.gov/study/NCT07627529","title":"Evaluating the Effect of Deprescribing Antimuscarinic Overactive Bladder Medications on Cognitive Function and Quality of Life of Individuals With Parkinson Disease: A Pharmacist-led Series of N-of-1 Trials","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Corporal Michael J. Crescenz VA Medical Center","sponsor_slug":"corporal-michael-j-crescenz-va-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03301805","publication_url":"https://clinicaltrials.gov/study/NCT03301805","title":"A Phase II, Open Label Study to Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Gemcitabine Monotherapy in Patients With Advanced Inoperable or Metastatic Pancreatic Cancer","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Rgene Corporation","sponsor_slug":"rgene-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07423546","publication_url":"https://clinicaltrials.gov/study/NCT07423546","title":"A Multimodal PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"New York State Psychiatric Institute","sponsor_slug":"new-york-state-psychiatric-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07638462","publication_url":"https://clinicaltrials.gov/study/NCT07638462","title":"RIsEStroke (Recovery Insights Into Early Mobility Post Stroke)","has_exemption":false,"start_date":"2026-07-08","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07732673","publication_url":"https://clinicaltrials.gov/study/NCT07732673","title":"The Use of Transcranial Direct Current Stimulation in the Rehabilitation of Post-Stroke Dysphagia During the Subacute Phase in Hospitalized Patients: A Randomized Clinical Trial","has_exemption":false,"start_date":"2026-07-16","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Juliane Lisboa Pereira","sponsor_slug":"juliane-lisboa-pereira","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07496463","publication_url":"https://clinicaltrials.gov/study/NCT07496463","title":"Setmelanotide to Treat Obesity in a Patient With Pseudohypoparathyroidism Type 1a (PHP1a)","has_exemption":false,"start_date":"2026-07-21","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07635563","publication_url":"https://clinicaltrials.gov/study/NCT07635563","title":"Phase II, Randomized, Double-Blind, Multidose Crossover Clinical Trial to Determine the Safety and Efficacy of IHL-42X in Subjects With Obstructive Sleep Apnea","has_exemption":false,"start_date":"2026-07-21","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Incannex Healthcare Ltd","sponsor_slug":"incannex-healthcare-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07641504","publication_url":"https://clinicaltrials.gov/study/NCT07641504","title":"Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY4065967 for the Treatment of Chronic Low Back Pain","has_exemption":false,"start_date":"2026-08-12","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07426822","publication_url":"https://clinicaltrials.gov/study/NCT07426822","title":"A Phase II Trial to Improve Safety of Capivasertib for HR+/HER2- Metastatic Breast Cancer","has_exemption":false,"start_date":"2026-08-15","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Maryam Lustberg","sponsor_slug":"maryam-lustberg","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07695688","publication_url":"https://clinicaltrials.gov/study/NCT07695688","title":"Feasibility Clinical Trial to Assess the Safety and Potential Effectiveness of Microlyte® DualGuard Wound Dressing on Surgically Created Partial-thickness Donor Site Wounds on Patients Requiring Split- Thickness Skin Grafting; the SAGGA Trial","has_exemption":false,"start_date":"2026-08-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Imbed Biosciences","sponsor_slug":"imbed-biosciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07629726","publication_url":"https://clinicaltrials.gov/study/NCT07629726","title":"A Phase 1/2, Multicenter, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KK2430 in Participants With Hematologic Neoplasms","has_exemption":false,"start_date":"2026-08-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Kyowa Kirin Co., Ltd.","sponsor_slug":"kyowa-kirin-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07520851","publication_url":"https://clinicaltrials.gov/study/NCT07520851","title":"Efficacy of the Buzzy System on Pain and Fear Reduction in Elbow Fracture Pin Removal","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07534332","publication_url":"https://clinicaltrials.gov/study/NCT07534332","title":"Therapeutic Targeting of Gasdermin D-Mediated Pyroptosis to Attenuate Joint Inflammation in Rheumatoid Arthritis","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07588802","publication_url":"https://clinicaltrials.gov/study/NCT07588802","title":"Effect of Opioid-Sparing Anesthesia on Postoperative Opioid Consumption and Pain in Spine Surgery","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07832136","publication_url":"https://clinicaltrials.gov/study/NCT07832136","title":"A Phase 4, Single-Arm, Open-Label Trial to Evaluate the Safety and Efficacy of Veligrotug in Participants With Thyroid Eye Disease (TED) Who Previously Responded to Teprotumumab","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Viridian Therapeutics, Inc.","sponsor_slug":"viridian-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07218432","publication_url":"https://clinicaltrials.gov/study/NCT07218432","title":"A Window of Opportunity Pilot Study: TheraBionic P1 Device for Patients With Resectable Early-stage Breast Cancer in a Neoadjuvant Setting","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Barbara Ann Karmanos Cancer Institute","sponsor_slug":"barbara-ann-karmanos-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07635719","publication_url":"https://clinicaltrials.gov/study/NCT07635719","title":"Comparative Analysis of Efficiency, Technical Performance, and Environmental Cost Between Reprocessed and New Coblator Wands in Intracapsular Tonsillectomies and Adenoidectomies","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07842978","publication_url":"https://clinicaltrials.gov/study/NCT07842978","title":"A Six-month Clinical Investigation of a Silica-free Meridol Toothpaste Versus Colgate Cavity Protection Toothpaste for the Control of Established Dental Plaque and Gingivitis","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Colgate Palmolive","sponsor_slug":"colgate-palmolive","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07853742","publication_url":"https://clinicaltrials.gov/study/NCT07853742","title":"Omadacycline for Treatment Refractory Mycoplasma Genitalium Urethritis","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07867158","publication_url":"https://clinicaltrials.gov/study/NCT07867158","title":"A Phase 2 Study of Boswellia for Treating Urinary Toxicity in Prostate Cancer Radiotherapy","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07881952","publication_url":"https://clinicaltrials.gov/study/NCT07881952","title":"COVE-5: A Phase 2, Open-label Study to Evaluate the Safety and Systemic Exposure of YCANTH (VP-102) in Subjects With Common Warts (Verruca Vulgaris)","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Verrica Pharmaceuticals Inc.","sponsor_slug":"verrica-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07832084","publication_url":"https://clinicaltrials.gov/study/NCT07832084","title":"OFF-RAMP Feasibility: a Pilot Trial Comparing Different Off-ramping Strategies for Maintaining Weight Loss Among Adults Using Incretin Based Therapies for Obesity","has_exemption":false,"start_date":"2026-11-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Jing Luo","sponsor_slug":"jing-luo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07647939","publication_url":"https://clinicaltrials.gov/study/NCT07647939","title":"Exclusion of Left Atrial Appendage Thrombus in Emergency Department Patients With Atrial Fibrillation Undergoing CT to Assess for Pulmonary Embolus: A Feasibility Study","has_exemption":false,"start_date":"2026-11-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07674810","publication_url":"https://clinicaltrials.gov/study/NCT07674810","title":"A Phase 2 Trial Of The Combination Of Zanubrutinib, Sonrotoclax, And Obinutuzumab For Patients With Treatment-Naïve Chronic Lymphocytic Leukemia","has_exemption":false,"start_date":"2026-12-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07893483","publication_url":"https://clinicaltrials.gov/study/NCT07893483","title":"Phase IIa Open Label Study to Evaluate the Safety, Tolerability, and Efficacy of Oral KM-023 in Adult Patients With Palmoplantar Epidermal Differentiation Disorders - Pachyonychia Congenita (pEDD-PC): KRT6A-pEDD-PC, KRT6B-pEDD-PC, KRT6C-pEDD-PC, KRT16-pEDD-PC and KRT17-pEDD-PC","has_exemption":false,"start_date":"2026-12-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Orvida Pharma (formerly Kamari Pharma)","sponsor_slug":"orvida-pharma-formerly-kamari-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07566312","publication_url":"https://clinicaltrials.gov/study/NCT07566312","title":"Anterior Versus Posterior Versus Lateral Quadratus Lumborum Block: a Randomized Control Trial in Healthy Volunteers","has_exemption":false,"start_date":"2027-01-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02438904","publication_url":"https://clinicaltrials.gov/study/NCT02438904","title":"Compassionate Access of the Miltenyi Device for CD34+ Cell Selection","has_exemption":false,"start_date":"2015-05-06","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03007030","publication_url":"https://clinicaltrials.gov/study/NCT03007030","title":"Phase II Trial of Adcetris (Brentuximab Vedotin) in CD30+ Malignant Mesothelioma","has_exemption":false,"start_date":"2017-04-05","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03793478","publication_url":"https://clinicaltrials.gov/study/NCT03793478","title":"A Phase 1/2, Multicenter, Dose-Escalating Study To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy Of Quizartinib Administered in Combination With Re-Induction Chemotherapy, and as a Single-Agent Continuation Therapy, in Pediatric Relapsed/Refractory AML Subjects Aged 1 Month to <18 Years (and Young Adults Aged up to 21 Years) With FLT3-ITD Mutations","has_exemption":false,"start_date":"2018-08-15","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03625752","publication_url":"https://clinicaltrials.gov/study/NCT03625752","title":"Optimization of Non-Invasive Brain Stimulation for Diabetic Neuropathy","has_exemption":false,"start_date":"2019-06-06","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Case Western Reserve University","sponsor_slug":"case-western-reserve-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04995562","publication_url":"https://clinicaltrials.gov/study/NCT04995562","title":"Use of Hyperpolarized 129Xe MR Lung Imaging in Infants","has_exemption":false,"start_date":"2020-05-06","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04472702","publication_url":"https://clinicaltrials.gov/study/NCT04472702","title":"Fluoroscopic Versus Ultrasound Guidance for Cooled Radiofrequency Ablation of Geniculate Nerves in Knee Osteoarthritis: A Randomized Control Trial","has_exemption":false,"start_date":"2022-02-02","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05358548","publication_url":"https://clinicaltrials.gov/study/NCT05358548","title":"Alternating Treatment Plans for Participants With Advanced Thoracic/Head & Neck Cancers (ATATcH)","has_exemption":false,"start_date":"2022-04-28","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05327647","publication_url":"https://clinicaltrials.gov/study/NCT05327647","title":"A Phase II Randomized Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer","has_exemption":false,"start_date":"2022-06-23","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"CHU de Quebec-Universite Laval","sponsor_slug":"chu-de-quebec-universite-laval","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05200442","publication_url":"https://clinicaltrials.gov/study/NCT05200442","title":"A Phase 1b/2 Study of AVUTOMETINIB and Cetuximab in Participants With Advanced KRAS Mutated Colorectal Cancer","has_exemption":false,"start_date":"2022-08-22","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05333458","publication_url":"https://clinicaltrials.gov/study/NCT05333458","title":"A Phase 2 Study of Atezolizumab With Selinexor in Alveolar Soft Part Sarcoma (AXIOM)","has_exemption":false,"start_date":"2022-08-29","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05313165","publication_url":"https://clinicaltrials.gov/study/NCT05313165","title":"Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia: The PROMISE III Trial","has_exemption":false,"start_date":"2022-12-22","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"LimFlow, Inc.","sponsor_slug":"limflow-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05524064","publication_url":"https://clinicaltrials.gov/study/NCT05524064","title":"FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases in the Thorax","has_exemption":false,"start_date":"2023-03-08","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Varian, a Siemens Healthineers Company","sponsor_slug":"varian-a-siemens-healthineers-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05331170","publication_url":"https://clinicaltrials.gov/study/NCT05331170","title":"Epigenetic Mechanism Reprogramming Mucosal Anti-viral Immunity in Allergic Asthma VIRAL MUCOSAL REPROGRAMMING","has_exemption":false,"start_date":"2023-04-27","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Medical Branch, Galveston","sponsor_slug":"the-university-of-texas-medical-branch-galveston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05669027","publication_url":"https://clinicaltrials.gov/study/NCT05669027","title":"Effective Self-Management of Chronic Pain With mHealth Neurofeedback","has_exemption":false,"start_date":"2023-10-02","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05755399","publication_url":"https://clinicaltrials.gov/study/NCT05755399","title":"Feasibility of Transcranial Focused Ultrasound to Measure Brain Tumor","has_exemption":false,"start_date":"2023-10-19","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04808427","publication_url":"https://clinicaltrials.gov/study/NCT04808427","title":"Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer","has_exemption":false,"start_date":"2023-11-20","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05938036","publication_url":"https://clinicaltrials.gov/study/NCT05938036","title":"PUERTA: A P2A Multi-center, Randomized, Double-blind, Placebo-controlled Study Assessing Safety and Efficacy of the eNAMPT Targeting mAb ALT-100 in Moderate/Severe ARDS/VILI Patients","has_exemption":false,"start_date":"2023-12-01","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Aqualung Therapeutics Corp.","sponsor_slug":"aqualung-therapeutics-corp","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05835505","publication_url":"https://clinicaltrials.gov/study/NCT05835505","title":"Detoxification of the Liver in Primary Sclerosing Cholangitis","has_exemption":false,"start_date":"2023-12-12","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06188702","publication_url":"https://clinicaltrials.gov/study/NCT06188702","title":"A Phase 1/2, Open-label, Multicenter Clinical Trial Investigating the Safety, Tolerability, Pharmacokinetics, and Antineoplastic Activity of S095035 (MAT2A Inhibitor) as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Homozygous Deletion of MTAP","has_exemption":false,"start_date":"2024-04-29","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Servier Bio-Innovation LLC","sponsor_slug":"servier-bio-innovation-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06265285","publication_url":"https://clinicaltrials.gov/study/NCT06265285","title":"MC230716 Pilot Single-Arm, Pragmatic Trial Of In-Home Versus In-Clinic Subcutaneous Nivolumab Administration Through Cancer CARE (Connected Access And Remote Expertise) Beyond Walls (CCBW) Program","has_exemption":false,"start_date":"2024-04-30","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06023329","publication_url":"https://clinicaltrials.gov/study/NCT06023329","title":"Superficial Cervical Plexus Block for Improved Outcomes in Pediatric Otolaryngologic Surgery","has_exemption":false,"start_date":"2024-05-31","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06096597","publication_url":"https://clinicaltrials.gov/study/NCT06096597","title":"Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS): a Prospective, Double-Blind, Randomized Controlled Trial","has_exemption":false,"start_date":"2024-07-24","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"David Sheyn","sponsor_slug":"david-sheyn","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06524414","publication_url":"https://clinicaltrials.gov/study/NCT06524414","title":"A Phase 2, Randomized, Double-Blind Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Infants","has_exemption":false,"start_date":"2024-07-25","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06308588","publication_url":"https://clinicaltrials.gov/study/NCT06308588","title":"Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia","has_exemption":false,"start_date":"2024-08-05","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06440525","publication_url":"https://clinicaltrials.gov/study/NCT06440525","title":"A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Impact of Intravenous RSLV-132 in Participants With Sjögren's Disease With Moderate to Severe Symptom Burden","has_exemption":false,"start_date":"2024-12-01","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Resolve Therapeutics","sponsor_slug":"resolve-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06548412","publication_url":"https://clinicaltrials.gov/study/NCT06548412","title":"CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers","has_exemption":false,"start_date":"2025-01-22","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06581328","publication_url":"https://clinicaltrials.gov/study/NCT06581328","title":"A Phase 4 Study Evaluating Moderate to Severely Active Ulcerative Colitis or Crohn's Disease and the Use of Vedolizumab Subcutaneous Within a Community Setting","has_exemption":false,"start_date":"2025-03-27","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06915727","publication_url":"https://clinicaltrials.gov/study/NCT06915727","title":"Pafolacianine for Localization of Pediatric Extracranial Solid Tumors","has_exemption":false,"start_date":"2025-04-15","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06709573","publication_url":"https://clinicaltrials.gov/study/NCT06709573","title":"Clinical Decision Support Assistance to Randomize Patients to Early or Late Adjunctive Vasopressin in Septic Shock","has_exemption":false,"start_date":"2025-04-29","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06424067","publication_url":"https://clinicaltrials.gov/study/NCT06424067","title":"A Phase II Study of Fingolimod in Patients With Non-Small Cell and Small Cell Lung Cancer","has_exemption":false,"start_date":"2025-05-01","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06627751","publication_url":"https://clinicaltrials.gov/study/NCT06627751","title":"Phase II Clinical Trial of Mezigdomide/Carfilzomib/Dexamethasone (MeziKD) in Patients With Relapsed or Refractory Multiple Myeloma (MM) With Extramedullary Disease (EMD)","has_exemption":false,"start_date":"2025-05-01","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06609265","publication_url":"https://clinicaltrials.gov/study/NCT06609265","title":"A Randomized, Double-blind, Dose-escalation, Sham-controlled Trial to Evaluate the Safety and Feasibility of Extracorporeal Shockwave Therapy (ESWT) for the Management of Stress Fractures and High-grade Bone Stress Injuries (BSIs)","has_exemption":false,"start_date":"2025-05-01","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06896903","publication_url":"https://clinicaltrials.gov/study/NCT06896903","title":"Analysis of Coronary Reactivity Testing With and Without Intracoronary Nitrate Testing","has_exemption":false,"start_date":"2025-05-21","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Baylor Research Institute","sponsor_slug":"baylor-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06834607","publication_url":"https://clinicaltrials.gov/study/NCT06834607","title":"Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Complex Aortic Aneurysms","has_exemption":false,"start_date":"2025-06-01","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Akhilesh Jain","sponsor_slug":"akhilesh-jain","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06943534","publication_url":"https://clinicaltrials.gov/study/NCT06943534","title":"Omalizumab Weight-Based Dosing Efficacy Trial","has_exemption":false,"start_date":"2025-07-03","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07513792","publication_url":"https://clinicaltrials.gov/study/NCT07513792","title":"The Impact of a 3D Imaging Visualization Tool for Orthodontic Treatment With Aligners in Reducing Periodontal Recession Occurrence","has_exemption":false,"start_date":"2025-09-04","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"University of Liege","sponsor_slug":"university-of-liege","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06928766","publication_url":"https://clinicaltrials.gov/study/NCT06928766","title":"Effects of Eszopiclone and Lemborexant in People With Obstructive Sleep Apnoea (OSA) With a Low Arousal Threshold Who Have Difficulty Maintaining or Falling Asleep (ELOSA): A Double-blind, Placebo-controlled, Randomised, Trial.","has_exemption":false,"start_date":"2025-10-31","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Flinders University","sponsor_slug":"flinders-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224971","publication_url":"https://clinicaltrials.gov/study/NCT07224971","title":"Assessing the Impact of Circadian Rhythm on Anti-PD-1/PD-L1 Immunotherapy","has_exemption":false,"start_date":"2025-12-02","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Liza Villaruz, MD","sponsor_slug":"liza-villaruz-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07161765","publication_url":"https://clinicaltrials.gov/study/NCT07161765","title":"Rectal Evacuation Disorders and Straining-associated Symptoms in Bleeding Hemorrhoids","has_exemption":false,"start_date":"2025-12-05","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217405","publication_url":"https://clinicaltrials.gov/study/NCT07217405","title":"Low-Dose Radiotherapy Compared to Corticosteroid Injection for Treatment of Hand Osteoarthritis","has_exemption":false,"start_date":"2025-12-19","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06810310","publication_url":"https://clinicaltrials.gov/study/NCT06810310","title":"Psilocybin: Capturing Brain Mechanisms of Motivation and Neurocognition in Individuals With Opioid Use Disorder","has_exemption":false,"start_date":"2025-12-22","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07285057","publication_url":"https://clinicaltrials.gov/study/NCT07285057","title":"Diagnostic Utility of rhPSMA-7.3 (18F) PET /CT Imaging in Patients With Prostate Cancer on Active Surveillance","has_exemption":false,"start_date":"2026-02-10","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07071961","publication_url":"https://clinicaltrials.gov/study/NCT07071961","title":"Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]","has_exemption":false,"start_date":"2026-02-11","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06751992","publication_url":"https://clinicaltrials.gov/study/NCT06751992","title":"Neurocognitive Function Changes With Once-Daily Extended-Release Tacrolimus (Envarsus XR) Conversion Compared to Twice-Daily Immediate Release Tacrolimus Maintenance Among Older Kidney Transplant Recipients","has_exemption":false,"start_date":"2026-03-17","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07431216","publication_url":"https://clinicaltrials.gov/study/NCT07431216","title":"A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression","has_exemption":false,"start_date":"2026-05-01","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Starlight Therapeutics Inc.","sponsor_slug":"starlight-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07096544","publication_url":"https://clinicaltrials.gov/study/NCT07096544","title":"CALM Study: Cardiomems Assisted Lvad Management","has_exemption":false,"start_date":"2026-05-08","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Baylor Research Institute","sponsor_slug":"baylor-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07563257","publication_url":"https://clinicaltrials.gov/study/NCT07563257","title":"Comparative Evaluation of Optrell and Octaray Mapping Catheters for Conduction Block Confirmation and Voltage Assessment During Atrial Ablation","has_exemption":false,"start_date":"2026-05-12","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Maxime Zabern","sponsor_slug":"maxime-zabern","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221292","publication_url":"https://clinicaltrials.gov/study/NCT07221292","title":"Effects of N-Acetyl-L-Leucine on CACNA1A Disorders: A Phase III, Randomized, Placebo-controlled, Double-blind, Crossover Study","has_exemption":false,"start_date":"2026-08-17","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"IntraBio Inc","sponsor_slug":"intrabio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07422532","publication_url":"https://clinicaltrials.gov/study/NCT07422532","title":"An Open-label, Multi-centre, Randomised Controlled Trial to Assess the Efficacy, Safety and Utility of Automated Insulin Delivery in People With Type 2 Diabetes and Sub-optimal Glycaemia Undergoing Haemodialysis","has_exemption":false,"start_date":"2026-09-01","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Imperial College London","sponsor_slug":"imperial-college-london","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04381897","publication_url":"https://clinicaltrials.gov/study/NCT04381897","title":"Use of N-Acetylcysteine (NAC) in the Treatment of Repetitive Behaviors (RB) and Self-Injurious Behaviors (SIB) in Cornelia de Lange Syndrome: A Randomized Double-Blind Placebo-Controlled Pilot Study","has_exemption":false,"start_date":"2026-11-01","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07899762","publication_url":"https://clinicaltrials.gov/study/NCT07899762","title":"Impact of Perioperative Nutritional Supplementation on Limb Circumference and Functional Recovery Following Elective Total Knee Arthroplasty: A Prospective Study","has_exemption":false,"start_date":"2027-01-01","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05362292","publication_url":"https://clinicaltrials.gov/study/NCT05362292","title":"Cognitive, Urinary, and Functional Trajectories of Older Women Using Pharmacologic Treatment Strategies for Urgency Incontinence","has_exemption":false,"start_date":"2022-10-04","completion_date":"2027-05-02","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07829029","publication_url":"https://clinicaltrials.gov/study/NCT07829029","title":"Ancillary Nocturnal Urinary Symptom Investigation in the TRIUMPH Trial","has_exemption":false,"start_date":"2022-10-04","completion_date":"2027-05-02","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06807268","publication_url":"https://clinicaltrials.gov/study/NCT06807268","title":"A 16-WEEK, MULTICENTER, INTERVENTIONAL, PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO INVESTIGATE EFFICACY AND SAFETY OF ABROCITINIB IN CHILDREN 6 TO LESS THAN 12 YEARS OF AGE WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS","has_exemption":false,"start_date":"2025-07-24","completion_date":"2027-05-02","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07647003","publication_url":"https://clinicaltrials.gov/study/NCT07647003","title":"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Two Fixed-Dose Leucine, Sildenafil and Metformin Combinations (NS-0200) Versus Placebo on Blood Pressure in Individuals With Hypertension","has_exemption":false,"start_date":"2026-10-15","completion_date":"2027-05-02","has_results":false,"results_due":false,"sponsor_name":"NuSirt Biopharma","sponsor_slug":"nusirt-biopharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04650568","publication_url":"https://clinicaltrials.gov/study/NCT04650568","title":"A Prospective Randomized Trial of Biologic Augmentation With Mesenchymal Stem Cells in Patients Undergoing Anterior Cruciate Ligament Reconstruction","has_exemption":false,"start_date":"2017-11-03","completion_date":"2027-05-03","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04784715","publication_url":"https://clinicaltrials.gov/study/NCT04784715","title":"Phase III Study of Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive, First-line Metastatic Breast Cancer (DESTINY-Breast09)","has_exemption":false,"start_date":"2021-04-26","completion_date":"2027-05-03","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04878094","publication_url":"https://clinicaltrials.gov/study/NCT04878094","title":"ARIA II: A Phase III Randomized Controlled Trial of Near-Infrared Angiography During Rectosigmoid Resection and Anastomosis in Women With Ovarian Cancer","has_exemption":false,"start_date":"2021-05-03","completion_date":"2027-05-03","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07139951","publication_url":"https://clinicaltrials.gov/study/NCT07139951","title":"Prophylactic Hyperthermic IntraperitOneal Chemotherapy (p-HIPEC) for pRevention of perItONeal Recurrence in Gastric Cancer: MC240402 (HORIZON) Trial","has_exemption":false,"start_date":"2025-12-03","completion_date":"2027-05-03","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02094794","publication_url":"https://clinicaltrials.gov/study/NCT02094794","title":"Phase II Study of Total Marrow and Lymphoid Irradiation (TMLI) Given in Combination With Cyclophosphamide and Etoposide as Conditioning for Allogeneic (HSCT) in Patients With High-Risk Acute Lymphocytic or Myelogenous Leukemia","has_exemption":false,"start_date":"2014-05-12","completion_date":"2027-05-04","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02628067","publication_url":"https://clinicaltrials.gov/study/NCT02628067","title":"A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects With Advanced Solid Tumors (KEYNOTE 158)","has_exemption":false,"start_date":"2015-12-18","completion_date":"2027-05-04","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04379596","publication_url":"https://clinicaltrials.gov/study/NCT04379596","title":"A Phase 1b/2 Multicenter, Open-label, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of Trastuzumab Deruxtecan (T-DXd) Monotherapy and Combinations in Adult Participants With HER2-expressing Gastric Cancer (DESTINY-Gastric-03)","has_exemption":false,"start_date":"2020-06-03","completion_date":"2027-05-04","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05972551","publication_url":"https://clinicaltrials.gov/study/NCT05972551","title":"A Phase 3, Open-Label, Multicenter, Randomized Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta","has_exemption":false,"start_date":"2024-04-22","completion_date":"2027-05-04","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07201051","publication_url":"https://clinicaltrials.gov/study/NCT07201051","title":"A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Investigate Efficacy, Safety, Immunogenicity, and Pharmacokinetics, of GSK3862995B in Participants With Bronchiectasis","has_exemption":false,"start_date":"2025-10-30","completion_date":"2027-05-04","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04380636","publication_url":"https://clinicaltrials.gov/study/NCT04380636","title":"A Phase 3 Study of Pembrolizumab (MK-3475) in Combination With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib vs Concurrent Chemoradiation Therapy Followed by Durvalumab in Participants With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2020-07-06","completion_date":"2027-05-05","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04978272","publication_url":"https://clinicaltrials.gov/study/NCT04978272","title":"Enhancing Immunity to Malaria in Young Children With Effective Chemoprevention","has_exemption":false,"start_date":"2022-02-08","completion_date":"2027-05-05","has_results":false,"results_due":false,"sponsor_name":"Grant Dorsey, M.D, Ph.D.","sponsor_slug":"grant-dorsey-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06428396","publication_url":"https://clinicaltrials.gov/study/NCT06428396","title":"A Phase 2, Randomized, Active-controlled, Open-label, Multicenter Study of Belzutifan Plus Fulvestrant in Participants With Estrogen Receptor Positive, HER2 Negative Unresectable Locally Advanced or Metastic Breast Cancer After Progression on Previous Endocrine Therapy (LITESPARK-029)","has_exemption":false,"start_date":"2024-11-27","completion_date":"2027-05-05","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06827054","publication_url":"https://clinicaltrials.gov/study/NCT06827054","title":"Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring Opioids","has_exemption":false,"start_date":"2026-09-15","completion_date":"2027-05-05","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04329039","publication_url":"https://clinicaltrials.gov/study/NCT04329039","title":"Randomized Control Trial Comparing Somatostatin Analogues With Perioperative Antibiotics Versus Prolonged Antibiotics","has_exemption":false,"start_date":"2020-11-17","completion_date":"2027-05-06","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05063162","publication_url":"https://clinicaltrials.gov/study/NCT05063162","title":"A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3, Pivotal Study With an Open-Label Extension Period to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disease (MOG-AD)","has_exemption":false,"start_date":"2022-02-02","completion_date":"2027-05-06","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06141473","publication_url":"https://clinicaltrials.gov/study/NCT06141473","title":"Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis","has_exemption":false,"start_date":"2023-12-13","completion_date":"2027-05-06","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06138639","publication_url":"https://clinicaltrials.gov/study/NCT06138639","title":"A Phase 1/2, Multicenter, Open-Label Study to Investigate the Safety, Tolerability, and Efficacy of a Single Intravenous Dose of SGT-003 in Males With Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)","has_exemption":false,"start_date":"2024-05-06","completion_date":"2027-05-06","has_results":false,"results_due":false,"sponsor_name":"Solid Biosciences Inc.","sponsor_slug":"solid-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07465913","publication_url":"https://clinicaltrials.gov/study/NCT07465913","title":"Outcomes of Direct Selective Laser Trabeculoplasty With the Post-treatment Addition of Combination Netarsudil and Latanoprost vs Latanoprost Monotherapy","has_exemption":false,"start_date":"2026-05-14","completion_date":"2027-05-06","has_results":false,"results_due":false,"sponsor_name":"Eye Centers of Southeast Texas","sponsor_slug":"eye-centers-of-southeast-texas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06239116","publication_url":"https://clinicaltrials.gov/study/NCT06239116","title":"A Study of RM-718 Weekly Formulation in Healthy Subjects With Obesity and in Patients With Obesity Due to MC4R Impairment","has_exemption":false,"start_date":"2024-03-05","completion_date":"2027-05-07","has_results":false,"results_due":false,"sponsor_name":"Rhythm Pharmaceuticals, Inc.","sponsor_slug":"rhythm-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06281977","publication_url":"https://clinicaltrials.gov/study/NCT06281977","title":"Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm","has_exemption":false,"start_date":"2024-05-08","completion_date":"2027-05-08","has_results":false,"results_due":false,"sponsor_name":"Ottawa Heart Institute Research Corporation","sponsor_slug":"ottawa-heart-institute-research-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07891780","publication_url":"https://clinicaltrials.gov/study/NCT07891780","title":"Pharmacokinetics and Safety of a Single Dose of Epinephrine Nasal Spray in Paediatric Allergy Patients","has_exemption":false,"start_date":"2026-09-28","completion_date":"2027-05-08","has_results":false,"results_due":false,"sponsor_name":"Hikma Pharmaceuticals USA Inc.","sponsor_slug":"hikma-pharmaceuticals-usa-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03229200","publication_url":"https://clinicaltrials.gov/study/NCT03229200","title":"Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib After Completion of Ibrutinib Clinical Trials.","has_exemption":false,"start_date":"2017-05-22","completion_date":"2027-05-10","has_results":false,"results_due":false,"sponsor_name":"Pharmacyclics Switzerland GmbH","sponsor_slug":"pharmacyclics-switzerland-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03564340","publication_url":"https://clinicaltrials.gov/study/NCT03564340","title":"A Phase 1/2 Study of REGN4018 (Ubamatamab), a MUC16×CD3 Bispecific Antibody, Administered Alone or in Combination With Cemiplimab in Patients With Recurrent Ovarian Cancer or Other Recurrent MUC16+ Cancers","has_exemption":false,"start_date":"2018-05-21","completion_date":"2027-05-10","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05030428","publication_url":"https://clinicaltrials.gov/study/NCT05030428","title":"A Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (VICTORION-2 PREVENT)","has_exemption":false,"start_date":"2021-11-23","completion_date":"2027-05-10","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06074588","publication_url":"https://clinicaltrials.gov/study/NCT06074588","title":"A Randomized, Open-label, Phase 3 Study of MK-2870 vs Chemotherapy (Docetaxel or Pemetrexed) in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations","has_exemption":false,"start_date":"2023-11-12","completion_date":"2027-05-10","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07498010","publication_url":"https://clinicaltrials.gov/study/NCT07498010","title":"The Role of Doxycycline in the Management of Postoperative Seromas: A Pilot Study","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-05-10","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07862738","publication_url":"https://clinicaltrials.gov/study/NCT07862738","title":"Comparing the Addition of Inspiratory Muscle Training (IMT) to Usual Care Physical Therapy in Hospitalized Patients With Heart Failure Awaiting Advanced Therapies: a Single-center Pilot Feasibility Study","has_exemption":false,"start_date":"2026-11-10","completion_date":"2027-05-10","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04262843","publication_url":"https://clinicaltrials.gov/study/NCT04262843","title":"Phase II Study of Evaluating the Efficacy of Total Marrow and Lymphoid Irradiation (TMLI) as the Conditioning Regimen for HLA-Haploidentical Hematopoietic Cell Transplantation in Patients With Myelodysplasia or Acute Leukemia","has_exemption":false,"start_date":"2020-02-06","completion_date":"2027-05-11","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06094010","publication_url":"https://clinicaltrials.gov/study/NCT06094010","title":"A Phase IIIb Multicenter, Single-arm, Open-label Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Patients With Influenza and Transmission of Influenza to Household Contacts","has_exemption":false,"start_date":"2023-11-22","completion_date":"2027-05-11","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05726383","publication_url":"https://clinicaltrials.gov/study/NCT05726383","title":"MISTOSUS: Iscador® P (Mistletoe) Immunotherapy To Improve Event Free Survival In Patients With Relapsed Resectable Osteosarcoma","has_exemption":false,"start_date":"2024-05-14","completion_date":"2027-05-11","has_results":false,"results_due":false,"sponsor_name":"Hackensack Meridian Health","sponsor_slug":"hackensack-meridian-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220642","publication_url":"https://clinicaltrials.gov/study/NCT07220642","title":"Efficacy and Safety of Cagrilintide for Weight Management in Participants With Overweight or Obesity","has_exemption":false,"start_date":"2025-11-05","completion_date":"2027-05-11","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07655570","publication_url":"https://clinicaltrials.gov/study/NCT07655570","title":"Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous Angiosarcoma","has_exemption":false,"start_date":"2026-08-19","completion_date":"2027-05-11","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07654283","publication_url":"https://clinicaltrials.gov/study/NCT07654283","title":"A Phase 2 Multi-center, Randomized, Open-label Study to Assess the Efficacy and Safety of AHB-137 in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B in the North America and Europe Regions","has_exemption":false,"start_date":"2026-09-01","completion_date":"2027-05-11","has_results":false,"results_due":false,"sponsor_name":"AusperBio Therapeutics Inc.","sponsor_slug":"ausperbio-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06411158","publication_url":"https://clinicaltrials.gov/study/NCT06411158","title":"Training for Urinary Leakage Improvement After Pregnancy","has_exemption":false,"start_date":"2024-11-12","completion_date":"2027-05-12","has_results":false,"results_due":false,"sponsor_name":"NICHD Pelvic Floor Disorders Network","sponsor_slug":"nichd-pelvic-floor-disorders-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220759","publication_url":"https://clinicaltrials.gov/study/NCT07220759","title":"Efficacy and Safety of Cagrilintide for Weight Management in Participants With Overweight or Obesity and Type 2 Diabetes","has_exemption":false,"start_date":"2025-11-05","completion_date":"2027-05-12","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05327114","publication_url":"https://clinicaltrials.gov/study/NCT05327114","title":"Phase 2/3, Multistage, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab Administered to Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","has_exemption":false,"start_date":"2022-09-23","completion_date":"2027-05-14","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07847814","publication_url":"https://clinicaltrials.gov/study/NCT07847814","title":"Evaluation of F&P Mask, US, 2026","has_exemption":false,"start_date":"2026-10-26","completion_date":"2027-05-14","has_results":false,"results_due":false,"sponsor_name":"Fisher and Paykel Healthcare","sponsor_slug":"fisher-and-paykel-healthcare","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05343013","publication_url":"https://clinicaltrials.gov/study/NCT05343013","title":"TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy","has_exemption":false,"start_date":"2022-06-06","completion_date":"2027-05-15","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05605535","publication_url":"https://clinicaltrials.gov/study/NCT05605535","title":"A Phase 2, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial Comparing Chemoimmunotherapy (Paclitaxel-Carboplatin-Oregovomab) Versus Chemotherapy (Paclitaxel-Carboplatin-Placebo) as Neoadjuvant Therapy in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma","has_exemption":false,"start_date":"2023-02-07","completion_date":"2027-05-15","has_results":false,"results_due":false,"sponsor_name":"CanariaBio Inc.","sponsor_slug":"canariabio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06448026","publication_url":"https://clinicaltrials.gov/study/NCT06448026","title":"Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squamous Cell Carcinoma","has_exemption":false,"start_date":"2024-11-21","completion_date":"2027-05-15","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06836609","publication_url":"https://clinicaltrials.gov/study/NCT06836609","title":"A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Two-Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Two Doses of ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)","has_exemption":false,"start_date":"2025-04-28","completion_date":"2027-05-15","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07285044","publication_url":"https://clinicaltrials.gov/study/NCT07285044","title":"Cancer CARE (Connected Access and Remote Expertise) Beyond Walls - Pilot, Phase 2 Clinical Trial to Evaluate Administration of Cancer-Directed Therapy in the Patient's Homes Versus in Clinic in the Florida Panhandle and Surrounding Areas","has_exemption":false,"start_date":"2025-12-18","completion_date":"2027-05-15","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07467720","publication_url":"https://clinicaltrials.gov/study/NCT07467720","title":"Study to Evaluate the Clinical Utility of Radiation Exposure Reduction (SECURE): Multi-site Rampart Guardian Peripheral Trial","has_exemption":false,"start_date":"2026-08-20","completion_date":"2027-05-15","has_results":false,"results_due":false,"sponsor_name":"Baylor Research Institute","sponsor_slug":"baylor-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06912646","publication_url":"https://clinicaltrials.gov/study/NCT06912646","title":"An Evaluation of the Effect of the Erchonia® EVRL™ for Prescription Home Use Application in Providing Temporary Relief From Idiopathic Peripheral Neuropathy Foot Pain","has_exemption":false,"start_date":"2025-05-01","completion_date":"2027-05-16","has_results":false,"results_due":false,"sponsor_name":"Erchonia Corporation","sponsor_slug":"erchonia-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06979375","publication_url":"https://clinicaltrials.gov/study/NCT06979375","title":"Phase 2, Multicentre, Randomised, Double-blind, Placebo-controlled Safety and Efficacy Study of CDR132L on Reverse Cardiac Remodelling in Participants With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy","has_exemption":false,"start_date":"2025-06-30","completion_date":"2027-05-16","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07819097","publication_url":"https://clinicaltrials.gov/study/NCT07819097","title":"AN INTERVENTIONAL PHASE 3 STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) PREFUSION F SUBUNIT VACCINE IN PARTICIPANTS 60 YEARS OF AGE AND OLDER","has_exemption":false,"start_date":"2026-09-09","completion_date":"2027-05-16","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03346135","publication_url":"https://clinicaltrials.gov/study/NCT03346135","title":"A Multicenter, Open-Label, Single Arm, Phase II Study of Daratumumab as Consolidation/Maintenance Therapy After Autologous Stem Cell Transplantation in Patients With Multiple Myeloma","has_exemption":false,"start_date":"2020-01-06","completion_date":"2027-05-17","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06647407","publication_url":"https://clinicaltrials.gov/study/NCT06647407","title":"A Parallel-group Prevention, Phase II, Partially Blinded, Multi-stage Study to Investigate the Immunogenicity and Safety of Pentavalent Meningococcal ABCYW Vaccine Formulations Compared With Licensed Meningococcal Vaccines When Administered Alone in Healthy Children (2 to 9 Years of Age) or Concomitantly With Routine Pediatric Vaccines in Toddlers (12 to 15 Months of Age) and Infants (2 Months of Age).","has_exemption":false,"start_date":"2024-11-05","completion_date":"2027-05-17","has_results":false,"results_due":false,"sponsor_name":"Sanofi Pasteur, a Sanofi Company","sponsor_slug":"sanofi-pasteur-a-sanofi-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06736041","publication_url":"https://clinicaltrials.gov/study/NCT06736041","title":"A Phase 3, Randomized, Modified Double-blind, Active-controlled, Parallel-group, 2-arm Study to Investigate the Safety and Immunogenicity of a 4-dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers","has_exemption":false,"start_date":"2024-12-18","completion_date":"2027-05-17","has_results":false,"results_due":false,"sponsor_name":"Sanofi Pasteur, a Sanofi Company","sponsor_slug":"sanofi-pasteur-a-sanofi-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06799000","publication_url":"https://clinicaltrials.gov/study/NCT06799000","title":"A Randomized, Double-blind, Double-dummy, Placebo-controlled, Multicenter, Phase 3 Study Assessing the Efficacy, Safety, and Tolerability of 2 Doses of Remibrutinib Over a 68-week Treatment Period in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa. (RECHARGE-1)","has_exemption":false,"start_date":"2025-01-31","completion_date":"2027-05-17","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220577","publication_url":"https://clinicaltrials.gov/study/NCT07220577","title":"A Multicenter, Randomized, Participant- and Investigator -Blinded, Placebo-controlled, Phase 2a Study to Assess the Efficacy, Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis","has_exemption":false,"start_date":"2025-11-10","completion_date":"2027-05-17","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07213778","publication_url":"https://clinicaltrials.gov/study/NCT07213778","title":"A Phase 3, Multicenter, Double-Blinded, Randomized Study to Evaluate REGN7508, a Factor XI Monoclonal Antibody, Versus Acetylsalicylic Acid for Prophylaxis of Symptomatic Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-ASPEN)","has_exemption":false,"start_date":"2025-11-24","completion_date":"2027-05-17","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07277660","publication_url":"https://clinicaltrials.gov/study/NCT07277660","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Moderate to Severe Atopic Dermatitis","has_exemption":false,"start_date":"2025-12-29","completion_date":"2027-05-17","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07482787","publication_url":"https://clinicaltrials.gov/study/NCT07482787","title":"A Phase 3, Multi-center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa","has_exemption":false,"start_date":"2026-07-21","completion_date":"2027-05-17","has_results":false,"results_due":false,"sponsor_name":"Paradigm Therapeutics","sponsor_slug":"paradigm-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06660667","publication_url":"https://clinicaltrials.gov/study/NCT06660667","title":"A Phase 1/2 Dose Escalation and Dose Expansion Study to Evaluate the Safety, Tolerability, and Efficacy of One-time Intravitreal Dose of SAR402663 in Participants With Neovascular Age-related Macular Degeneration","has_exemption":false,"start_date":"2024-11-21","completion_date":"2027-05-18","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06671483","publication_url":"https://clinicaltrials.gov/study/NCT06671483","title":"A Multi-Center, Randomized, Double-Blind, Placebo- and Active-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Who Are Naïve to Biologic Disease-Modifying Antirheumatic Drugs (LATITUDE-PsA-3001)","has_exemption":false,"start_date":"2025-03-03","completion_date":"2027-05-18","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06671496","publication_url":"https://clinicaltrials.gov/study/NCT06671496","title":"A Multi-Center, Randomized, Double-Blind, and Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Stratified by Prior Biologic Use (LATITUDE-PsA-3002)","has_exemption":false,"start_date":"2025-03-10","completion_date":"2027-05-18","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07745504","publication_url":"https://clinicaltrials.gov/study/NCT07745504","title":"A Placebo-controlled Comparability Study to Compare Two Presentations of Cagrilintide for Weight Management in Participants With Overweight or Obesity","has_exemption":false,"start_date":"2026-08-04","completion_date":"2027-05-18","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04803201","publication_url":"https://clinicaltrials.gov/study/NCT04803201","title":"A Randomized Phase II Study of CHO(E)P vs CC-486-CHO(E)P vs Duvelisib-CHO(E)P in Previously Untreated CD30 Negative Peripheral T-Cell Lymphomas","has_exemption":false,"start_date":"2021-10-08","completion_date":"2027-05-19","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05624554","publication_url":"https://clinicaltrials.gov/study/NCT05624554","title":"A Phase 3, Randomized Study to Compare the Efficacy and Safety of Nemtabrutinib Versus Chemoimmunotherapy for Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Without TP53 Aberrations","has_exemption":false,"start_date":"2023-03-16","completion_date":"2027-05-19","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07558148","publication_url":"https://clinicaltrials.gov/study/NCT07558148","title":"Pilot Study to Investigate Brain Targets for Neuromodulation in Obsessive-compulsive Disorder","has_exemption":false,"start_date":"2026-03-04","completion_date":"2027-05-19","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01473628","publication_url":"https://clinicaltrials.gov/study/NCT01473628","title":"Randomized Trial of Radiation Therapy With and Without Rituximab for Patients With Stage I II Follicular Lymphoma Grade I/II","has_exemption":false,"start_date":"2013-05-20","completion_date":"2027-05-20","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03958877","publication_url":"https://clinicaltrials.gov/study/NCT03958877","title":"An Open-Label, Randomized, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in Pediatric Subjects Aged 10 to Less Than 18 Years for the Treatment of Relapsing-Remitting Multiple Sclerosis, With Optional Open-Label Extension","has_exemption":false,"start_date":"2019-10-18","completion_date":"2027-05-20","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06401707","publication_url":"https://clinicaltrials.gov/study/NCT06401707","title":"PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest","has_exemption":false,"start_date":"2024-05-20","completion_date":"2027-05-20","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06426498","publication_url":"https://clinicaltrials.gov/study/NCT06426498","title":"Developing a Method of Adjusting the Strength of Transcranial Focused Ultrasound (tFUS) to Personalize Treatment.","has_exemption":false,"start_date":"2024-06-20","completion_date":"2027-05-20","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06465329","publication_url":"https://clinicaltrials.gov/study/NCT06465329","title":"A Randomized Phase 2 Platform Study to Evaluate Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for the Perioperative Treatment of Patients With Resectable Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2024-11-18","completion_date":"2027-05-20","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06311227","publication_url":"https://clinicaltrials.gov/study/NCT06311227","title":"A Phase 2 Study of Venetoclax in Relapsed Classic or Variant Hairy Cell Leukemia","has_exemption":false,"start_date":"2024-12-16","completion_date":"2027-05-20","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04305834","publication_url":"https://clinicaltrials.gov/study/NCT04305834","title":"A Phase IIA Trial Assessing the Tolerability of Abemaciclib in Combination With Endocrine Therapy in Patients Age 70 and Older With Hormone Receptor Positive Metastatic Breast Cancer Who Have Progressed on or After Prior CDK 4/6 Inhibition","has_exemption":false,"start_date":"2020-06-05","completion_date":"2027-05-21","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05036226","publication_url":"https://clinicaltrials.gov/study/NCT05036226","title":"Combination of Autophagy Selective Therapeutics (COAST) in Advanced Solid Tumors or Relapsed Prostate Cancer, A Phase I/II Trial","has_exemption":false,"start_date":"2022-03-03","completion_date":"2027-05-21","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05132504","publication_url":"https://clinicaltrials.gov/study/NCT05132504","title":"Phase II Study of Neoadjuvant Folfirinox Chemotherapy Followed by Pembrolizumab Followed by Surgery for Patients With Localized, Resectable Adenocarcinoma of the Pancreas","has_exemption":false,"start_date":"2022-08-31","completion_date":"2027-05-21","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07227831","publication_url":"https://clinicaltrials.gov/study/NCT07227831","title":"A Phase 2 Study of TheraBionic P1 Device for Patients With Metastatic Hormone Positive Breast Cancer Post Endocrine Therapy","has_exemption":false,"start_date":"2026-01-16","completion_date":"2027-05-22","has_results":false,"results_due":false,"sponsor_name":"Barbara Ann Karmanos Cancer Institute","sponsor_slug":"barbara-ann-karmanos-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05886634","publication_url":"https://clinicaltrials.gov/study/NCT05886634","title":"A Phase II Study of Adenosine Receptor (A2A and A2B) Inhibition (AB928) in Combination With Anti-PD-1 Therapy (AB122) in Patients With Advanced Dedifferentiated Liposarcoma","has_exemption":false,"start_date":"2023-05-23","completion_date":"2027-05-23","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07049159","publication_url":"https://clinicaltrials.gov/study/NCT07049159","title":"A Two-stage, Phase 2b, Randomized, Double-blind, Placebo-controlled Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old","has_exemption":false,"start_date":"2025-06-30","completion_date":"2027-05-23","has_results":false,"results_due":false,"sponsor_name":"Eveliqure Biotechnologies GmbH","sponsor_slug":"eveliqure-biotechnologies-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06157567","publication_url":"https://clinicaltrials.gov/study/NCT06157567","title":"Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System","has_exemption":false,"start_date":"2022-05-24","completion_date":"2027-05-24","has_results":false,"results_due":false,"sponsor_name":"Candela Corporation","sponsor_slug":"candela-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05865028","publication_url":"https://clinicaltrials.gov/study/NCT05865028","title":"Phase II A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia","has_exemption":false,"start_date":"2023-05-24","completion_date":"2027-05-24","has_results":false,"results_due":false,"sponsor_name":"Elizabeth J Franzmann","sponsor_slug":"elizabeth-j-franzmann","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05067140","publication_url":"https://clinicaltrials.gov/study/NCT05067140","title":"A Phase 1/2 Open-Label, Dose-Escalation and Cohort Expansion Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ARV-766 Monotherapy and in Combination With Abiraterone in Patients With Metastatic Prostate Cancer","has_exemption":false,"start_date":"2021-09-02","completion_date":"2027-05-25","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05440708","publication_url":"https://clinicaltrials.gov/study/NCT05440708","title":"REVERT- Liver Cancer: A Phase 1b/2 Multicenter, Open-label Study to Evaluate the Safety and Efficacy of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma","has_exemption":false,"start_date":"2023-03-23","completion_date":"2027-05-25","has_results":false,"results_due":false,"sponsor_name":"Tvardi Therapeutics, Incorporated","sponsor_slug":"tvardi-therapeutics-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06327113","publication_url":"https://clinicaltrials.gov/study/NCT06327113","title":"A Phase 2 Randomized Study Comparing Subcutaneous Tumescent Antibiotic Administration With Standard of Care for the Treatment of Chronic Wounds","has_exemption":false,"start_date":"2024-05-17","completion_date":"2027-05-25","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06727578","publication_url":"https://clinicaltrials.gov/study/NCT06727578","title":"A Pilot Assessment of the Safety and Efficacy of Pleural Irrigation for Retained Pleural Infection Using a Novel Irrigation Device","has_exemption":false,"start_date":"2025-05-25","completion_date":"2027-05-25","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07151937","publication_url":"https://clinicaltrials.gov/study/NCT07151937","title":"A Seamless Phase 2a/2b, Randomized, Double-Blind, Placebo- and Active-Controlled, Multiple-Arm, Multiple-Stage, Adaptive Study Evaluating the Efficacy and Safety of LAD191 in Adults With Moderate-to-Severe Hidradenitis Suppurativa","has_exemption":false,"start_date":"2025-11-05","completion_date":"2027-05-25","has_results":false,"results_due":false,"sponsor_name":"Almirall, S.A.","sponsor_slug":"almirall-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07125872","publication_url":"https://clinicaltrials.gov/study/NCT07125872","title":"Open Label, Phase 2 Study of CD19 t-haNK and N-803 in Combination With Rituximab in Participants With Relapsed/ Refractory B-cell Non- Hodgkin Lymphoma","has_exemption":false,"start_date":"2025-11-11","completion_date":"2027-05-25","has_results":false,"results_due":false,"sponsor_name":"ImmunityBio, Inc.","sponsor_slug":"immunitybio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04458610","publication_url":"https://clinicaltrials.gov/study/NCT04458610","title":"BTK Inhibitor Zanubrutinib (BGB-3111) in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL)","has_exemption":false,"start_date":"2020-05-26","completion_date":"2027-05-26","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06008158","publication_url":"https://clinicaltrials.gov/study/NCT06008158","title":"Prospective Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation in Low-Risk, Hormone-Responsive Breast Cancer","has_exemption":false,"start_date":"2023-09-29","completion_date":"2027-05-26","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06453213","publication_url":"https://clinicaltrials.gov/study/NCT06453213","title":"Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy","has_exemption":false,"start_date":"2024-10-14","completion_date":"2027-05-26","has_results":false,"results_due":false,"sponsor_name":"SK Life Science, Inc.","sponsor_slug":"sk-life-science-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06782490","publication_url":"https://clinicaltrials.gov/study/NCT06782490","title":"A Phase 2, Randomized, Double-Blind, Four-Arm, Placebo-Controlled, Multicenter Study Assessing the Efficacy, Safety and Tolerability of Three Doses of Orally Administered BMS-986368, a FAAH/MAGL Inhibitor, for the Treatment of Spasticity in Participants With Multiple Sclerosis (BALANCE-MSS-1)","has_exemption":false,"start_date":"2025-06-05","completion_date":"2027-05-26","has_results":false,"results_due":false,"sponsor_name":"Celgene","sponsor_slug":"celgene","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04342429","publication_url":"https://clinicaltrials.gov/study/NCT04342429","title":"RAD4649-19: Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer","has_exemption":false,"start_date":"2020-03-19","completion_date":"2027-05-27","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05173987","publication_url":"https://clinicaltrials.gov/study/NCT05173987","title":"A Phase 3 Randomized, Open-label, Active-comparator Controlled Clinical Study of Pembrolizumab Versus Platinum Doublet Chemotherapy in Participants With Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma in the First-line Setting (KEYNOTE-C93/GOG-3064/ENGOT-en15)","has_exemption":false,"start_date":"2022-02-03","completion_date":"2027-05-27","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05973773","publication_url":"https://clinicaltrials.gov/study/NCT05973773","title":"Randomized, Controlled, Open-label, Phase 3, Global Multi - Center Trial to Assess the Efficacy and Safety of Zipalertinib Plus Chemotherapy Versus Chemotherapy Alone, in Patients With Previously Untreated, Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations","has_exemption":false,"start_date":"2023-12-18","completion_date":"2027-05-27","has_results":false,"results_due":false,"sponsor_name":"Taiho Oncology, Inc.","sponsor_slug":"taiho-oncology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07759154","publication_url":"https://clinicaltrials.gov/study/NCT07759154","title":"A Phase 3b, Multicenter, Open-label, Single-arm Trial to Evaluate the Efficacy and Safety of Orally Administered Centanafadine QD XR Capsules in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation","has_exemption":false,"start_date":"2026-09-01","completion_date":"2027-05-27","has_results":false,"results_due":false,"sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","sponsor_slug":"otsuka-pharmaceutical-development-commercialization-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04055649","publication_url":"https://clinicaltrials.gov/study/NCT04055649","title":"Phase II Study of ONC201 Plus Weekly Paclitaxel in Patients With Platinum-Resistant Refractory or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","has_exemption":false,"start_date":"2020-01-21","completion_date":"2027-05-28","has_results":false,"results_due":false,"sponsor_name":"Ira Winer","sponsor_slug":"ira-winer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04644068","publication_url":"https://clinicaltrials.gov/study/NCT04644068","title":"A Modular Phase I/IIa, Open-label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Ascending Doses of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies","has_exemption":false,"start_date":"2020-11-12","completion_date":"2027-05-28","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04916249","publication_url":"https://clinicaltrials.gov/study/NCT04916249","title":"Tibetree Pain-Relieving Plaster for Musculoskeletal Pain Among Cancer Survivors","has_exemption":false,"start_date":"2021-05-28","completion_date":"2027-05-28","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06016855","publication_url":"https://clinicaltrials.gov/study/NCT06016855","title":"Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy (PRRT) in Patients With Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors","has_exemption":false,"start_date":"2024-05-31","completion_date":"2027-05-28","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt-Ingram Cancer Center","sponsor_slug":"vanderbilt-ingram-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06449001","publication_url":"https://clinicaltrials.gov/study/NCT06449001","title":"A Phase 3 Open-Label Study of Danicopan as Add-on Treatment to Ravulizumab or Eculizumab in Pediatric Participants With Paroxysmal Nocturnal Hemoglobinuria Who Have Clinically Significant Extravascular Hemolysis","has_exemption":false,"start_date":"2025-08-11","completion_date":"2027-05-28","has_results":false,"results_due":false,"sponsor_name":"Alexion Pharmaceuticals, Inc.","sponsor_slug":"alexion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07465224","publication_url":"https://clinicaltrials.gov/study/NCT07465224","title":"A Randomized, Double-blind, Placebo-controlled Study Investigating the Effect of ALN-4324 on Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus","has_exemption":false,"start_date":"2026-01-15","completion_date":"2027-05-28","has_results":false,"results_due":false,"sponsor_name":"Alnylam Pharmaceuticals","sponsor_slug":"alnylam-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07672405","publication_url":"https://clinicaltrials.gov/study/NCT07672405","title":"A Phase 2b, Randomised, Multi-center, Partially Blinded Trial Assessing the Safety and Efficacy of Regimens Containing Sorfequiline, Pretomanid and Linezolid in Adults With Newly Diagnosed, Drug-sensitive, Smear Positive Pulmonary Tuberculosis","has_exemption":false,"start_date":"2026-07-09","completion_date":"2027-05-28","has_results":false,"results_due":false,"sponsor_name":"Global Alliance for TB Drug Development","sponsor_slug":"global-alliance-for-tb-drug-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07619118","publication_url":"https://clinicaltrials.gov/study/NCT07619118","title":"A Phase III Randomised, Double-Blind, Parallel-Group Study to Assess the Effect of Fixed Dose Combination Laroprovstat/Rosuvastatin Compared With Rosuvastatin on Low-Density Lipoprotein Cholesterol in Patients With Hypercholesterolaemia","has_exemption":false,"start_date":"2026-09-10","completion_date":"2027-05-28","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05284747","publication_url":"https://clinicaltrials.gov/study/NCT05284747","title":"EVOLVE-MI: A Pragmatic Randomized Multicenter Trial of EVOLocumab Administered Very Early to Reduce the Risk of Cardiovascular Events in Patients Hospitalized With Acute Myocardial Infarction","has_exemption":false,"start_date":"2022-10-26","completion_date":"2027-05-29","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07026877","publication_url":"https://clinicaltrials.gov/study/NCT07026877","title":"A Prospective, Multicenter, Non-Blinded, Non-Randomized Pivotal Study of the Fenestrated TREO Stent-Graft System in Subjects With Abdominal Aortic Aneurysms Requiring a Fenestrated Graft and Suitable for Endovascular Repair","has_exemption":false,"start_date":"2025-11-18","completion_date":"2027-05-29","has_results":false,"results_due":false,"sponsor_name":"Bolton Medical","sponsor_slug":"bolton-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04128670","publication_url":"https://clinicaltrials.gov/study/NCT04128670","title":"Effects of Kinesio Tape on Delayed Onset Muscle Soreness","has_exemption":false,"start_date":"2020-01-30","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04910022","publication_url":"https://clinicaltrials.gov/study/NCT04910022","title":"A Phase I/II Combination Study of NMS-03305293 and Temozolomide in Adult Patients With Recurrent Glioblastoma","has_exemption":false,"start_date":"2021-12-01","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"Nerviano Medical Sciences","sponsor_slug":"nerviano-medical-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05097976","publication_url":"https://clinicaltrials.gov/study/NCT05097976","title":"An Oral Methylprednisolone Taper Within a Multimodal Analgesic Regimen After Total Knee Arthroplasty: a Double-Blind Randomized Placebo-Controlled Trial","has_exemption":false,"start_date":"2022-03-01","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05548296","publication_url":"https://clinicaltrials.gov/study/NCT05548296","title":"A Phase 2 Study of ACR-368 Therapy in Subjects With Endometrial Cancer","has_exemption":false,"start_date":"2022-08-29","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"Acrivon Therapeutics","sponsor_slug":"acrivon-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05786417","publication_url":"https://clinicaltrials.gov/study/NCT05786417","title":"A Trial Comparing the Effectiveness and Tolerability of Medications in Older Adults With Stable Angina and Multiple Chronic Conditions: LIVEBETTER","has_exemption":false,"start_date":"2023-05-10","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06436612","publication_url":"https://clinicaltrials.gov/study/NCT06436612","title":"Phase II Study of Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy for Abdominopelvic Sarcomas (MARS Trial)","has_exemption":false,"start_date":"2024-05-30","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06561087","publication_url":"https://clinicaltrials.gov/study/NCT06561087","title":"Phase II Randomized, Placebo- Controlled Study of Intralesional Nivolumab for High-risk Oral Premalignant Lesions","has_exemption":false,"start_date":"2025-02-27","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06476132","publication_url":"https://clinicaltrials.gov/study/NCT06476132","title":"Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients: A Randomized, Multicenter, Double Blind, Placebo-Controlled Trial (CTOT-47)","has_exemption":false,"start_date":"2025-03-12","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06916286","publication_url":"https://clinicaltrials.gov/study/NCT06916286","title":"A Prospective, Randomized, Multi-center Trial Evaluating the Effect of Surgical Drain Securement on Patient Quality of Life and Postoperative Drain-related Complications","has_exemption":false,"start_date":"2025-05-05","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06982820","publication_url":"https://clinicaltrials.gov/study/NCT06982820","title":"A Prospective, Randomized, Double-blind, Controlled Study to Produce Guidelines for Integrating Prism for MDD Therapy (Reward System [RS] Upregulation) and to Demonstrate Its Superiority Over Sham Therapy","has_exemption":false,"start_date":"2025-06-25","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"GrayMatters Health Ltd.","sponsor_slug":"graymatters-health-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06793423","publication_url":"https://clinicaltrials.gov/study/NCT06793423","title":"Non-Significant Risk (NSR) Device Study to Evaluate Device Performance on Pigmented, Non-/Pigmented Skin Lesions and Histological Diagnoses: TruScore Standalone Clinical Study","has_exemption":false,"start_date":"2025-09-25","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"VeriSkin, Inc.","sponsor_slug":"veriskin-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04480619","publication_url":"https://clinicaltrials.gov/study/NCT04480619","title":"Safety and Efficacy of Ga-68-IAC Positron Emission Tomography (PET/CT) for Diagnosis and Clinical Management in Metastatic Breast Cancer Patients.","has_exemption":false,"start_date":"2025-10-30","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"Advanced Imaging Projects, LLC","sponsor_slug":"advanced-imaging-projects-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07605806","publication_url":"https://clinicaltrials.gov/study/NCT07605806","title":"Novel Biomarkers of Non-IgE Immediate Hypersensitivity Drug Reactions","has_exemption":false,"start_date":"2026-05-21","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07433699","publication_url":"https://clinicaltrials.gov/study/NCT07433699","title":"Image-Guided DBS Programming","has_exemption":false,"start_date":"2026-09-01","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07752108","publication_url":"https://clinicaltrials.gov/study/NCT07752108","title":"A Phase 3b, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Moderate-to-severe Non-pustular Palmoplantar Psoriasis (PPPsO)","has_exemption":false,"start_date":"2026-11-01","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00107289","publication_url":"https://clinicaltrials.gov/study/NCT00107289","title":"Open Access Protocol of Targeted Radiotherapy With I-metaiodobenzylguanidine (I-MIBG) in Patients With Resistant Neuroblastoma or Malignant Chromaffin Cell Tumors","has_exemption":false,"start_date":"2006-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00492999","publication_url":"https://clinicaltrials.gov/study/NCT00492999","title":"A Phase II Study of the Rate of Conversion to Complete Resection in Patients With Initially Inoperable Hepatic-Only Metastases From Colorectal Cancer After Treatment With Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Best Systemic Chemotherapy","has_exemption":false,"start_date":"2007-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01370512","publication_url":"https://clinicaltrials.gov/study/NCT01370512","title":"Treatment Trial of Droxidopa and Pyridostigmine to Improve Orthostatic Hypotension Without Aggravating Supine Hypertension","has_exemption":false,"start_date":"2011-11-30","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01864109","publication_url":"https://clinicaltrials.gov/study/NCT01864109","title":"A Phase II Trial of Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma","has_exemption":false,"start_date":"2013-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02450708","publication_url":"https://clinicaltrials.gov/study/NCT02450708","title":"Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes","has_exemption":false,"start_date":"2015-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02656511","publication_url":"https://clinicaltrials.gov/study/NCT02656511","title":"Immediate Initiation of Antiretroviral Therapy During Acute HIV Infection","has_exemption":false,"start_date":"2015-12-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02127398","publication_url":"https://clinicaltrials.gov/study/NCT02127398","title":"Fecal Microbiota Transplantation in Refractory Clostridium Difficile Colitis","has_exemption":false,"start_date":"2016-04-30","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02750358","publication_url":"https://clinicaltrials.gov/study/NCT02750358","title":"Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR(+) Triple Negative Breast Cancer","has_exemption":false,"start_date":"2016-05-19","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02780310","publication_url":"https://clinicaltrials.gov/study/NCT02780310","title":"A Phase II Study of Lenvatinib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma","has_exemption":false,"start_date":"2016-05-19","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02727803","publication_url":"https://clinicaltrials.gov/study/NCT02727803","title":"Personalized NK Cell Therapy in CBT","has_exemption":false,"start_date":"2016-05-19","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02595944","publication_url":"https://clinicaltrials.gov/study/NCT02595944","title":"Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers","has_exemption":false,"start_date":"2016-07-22","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03128879","publication_url":"https://clinicaltrials.gov/study/NCT03128879","title":"A Phase II Study of Venetoclax (ABT-199) Consolidation for Patients Currently Receiving Ibrutinib or Acalabrutinib for High-risk CLL","has_exemption":false,"start_date":"2017-06-16","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03110926","publication_url":"https://clinicaltrials.gov/study/NCT03110926","title":"Induction Chemotherapy for Locally Advanced Esophageal Cancer: A Phase II Study","has_exemption":false,"start_date":"2017-06-19","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Rochester","sponsor_slug":"university-of-rochester","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03233399","publication_url":"https://clinicaltrials.gov/study/NCT03233399","title":"Modulating Movement Intention Via Cortical Stimulation in Healthy Subjects and Patients With Psychogenic Movement Disorders and Non-epileptic Seizures","has_exemption":false,"start_date":"2017-07-20","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03384836","publication_url":"https://clinicaltrials.gov/study/NCT03384836","title":"A Phase Ib/II Study of Propranolol With Fixed-Dose Pembrolizumab in Patients With Unresectable Stage III and Stage IV Melanoma","has_exemption":false,"start_date":"2018-01-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03667651","publication_url":"https://clinicaltrials.gov/study/NCT03667651","title":"THE PEBBLES STUDY: A Randomised Controlled Trial to Prevent Eczema, Food Allergy and Sensitisation Using a Skin Barrier Improvement Strategy","has_exemption":false,"start_date":"2018-03-06","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Melbourne","sponsor_slug":"university-of-melbourne","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03506334","publication_url":"https://clinicaltrials.gov/study/NCT03506334","title":"Prospective Pilot Study of Anterior Vertebral Body Tethering Using Zimmer Biomet Tether System or Dynesys System Components to Treat Pediatric Scoliosis","has_exemption":false,"start_date":"2018-04-25","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03632044","publication_url":"https://clinicaltrials.gov/study/NCT03632044","title":"Evaluation of Trigeminal Nerve Blockade in the Pterygopalatine Fossa for Cleft Palate Repair: a Pilot Study","has_exemption":false,"start_date":"2018-11-20","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03598595","publication_url":"https://clinicaltrials.gov/study/NCT03598595","title":"A Phase 1/2 Study of Gemcitabine and Docetaxel in Combination With Hydroxychloroquine (Autophagy Inhibitor) in Patients With Recurrent Osteosarcoma","has_exemption":false,"start_date":"2019-01-28","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03898479","publication_url":"https://clinicaltrials.gov/study/NCT03898479","title":"A Multicenter, Open-Label, Extension Study to Assess the Long-Term Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata","has_exemption":false,"start_date":"2019-04-04","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Sun Pharmaceutical Industries, Inc.","sponsor_slug":"sun-pharmaceutical-industries-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04002947","publication_url":"https://clinicaltrials.gov/study/NCT04002947","title":"A Phase 2 Study of Acalabrutinib With DA-EPOCH-R or R-CHOP for Patients With Untreated Diffuse Large B-cell Lymphoma","has_exemption":false,"start_date":"2019-08-05","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04018859","publication_url":"https://clinicaltrials.gov/study/NCT04018859","title":"A Pilot Clinical Trial Investigating the Effect of Autologous Platelet-rich Plasma in Subjects With Mild to Moderate Eyebrow Hypotrichosis","has_exemption":false,"start_date":"2019-09-25","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03707262","publication_url":"https://clinicaltrials.gov/study/NCT03707262","title":"Donor Chimerism and Graft Survival Following Combined HLA-Identical Sibling Living Donor Kidney and Hematopoietic Stem Cell Transplantation Utilizing a Conditioning Regimen of Total Lymphoid Irradiation and Rabbit Anti-Thymocyte Globulin","has_exemption":false,"start_date":"2019-11-06","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Jeffrey Veale, MD","sponsor_slug":"jeffrey-veale-md","status":"ongoing","is_pact":false,"days_late":null}]}